Get started

Trend Analysis

Impulse completed?EUR/USD maintains its bullish trend intact after a sharp rally last week. The pair keeps consolidating gains as the 4-hour Relative Strength Index pulls back from overbought levels and price action is constrained within a 70-pip range, right below a nearly four-year high at 1.1750. Today, price hit upside target at the 161.8% Fibonacci extension level of the June 10-12 rally at 1.1795. I Think we might see a correction for the eurusd as the impulse seems to be completed.
by TRADINGACPVIP
Bullish ABC Hello awesome traders! I hope you're having a great trading week so far. This week is a bit shorter due to the U.S. Independence Day — with partial closures Thursday and a full close on Friday. But as always, we keep doing what we do best: identifying high-probability patterns, managing our risk, and pulling pips out of the market. Let’s break down this solid technical opportunity shaping up on CADJPY (4H) – presenting a bullish ABC structure into PCZ with clean symmetry and mapped targets. Pattern Overview: Pattern Type: ABC Bullish Asset: CADJPY Timeframe: 4H Trade Type: Long – Bullish impulse expected from confirmed completion at PCZ Key Levels: A Point: 103.819 – Major swing low off the 200 EMA B Point: 107.334 – Recent swing high, strong resistance reversal C Point: 104.837 – Completion zone aligning with fib extension confluence Entry Level (EL): 105.100–105.200 – Price now entering PCZ with reversal structure Stop Level (ST): Below 104.780 – Invalidation if structure fails Target 1 Zone: 107.000–107.600 – Key retracement and 78.6% cluster PCZ (Potential Completion Zone): 127.2–161.8% BC extension @ 105.402–104.876 Fibonacci Extensions & Key Ratios: BC 127.2%: 105.402 – First PRZ alert BC 161.8%: 104.876 – Extended completion zone AB=CD (Symmetry): Confirmed with nearly equal projection 38.2%–78.6% Retracement: 106.180–107.600 – Major resistance for profit-taking Price Action & Setup: Strong downside correction from B (107.334) to C (104.837) completed with confluence at PCZ. Price is reacting near the 200 EMA and forming a minor reversal wick. ABCD symmetry leg confirms with C leg near equal length projection from A–B. If bullish momentum confirms, a move back toward the retracement zones is expected. Market Sentiment: Market testing the PCZ zone with wicks forming — early buyers showing presence. 200 EMA support coincides with D-leg completion, a common bounce area in structure trades. No major USD flows this week due to holiday impact — JPY and CAD flows dominate. Next Potential Movement: Reversal confirmation from PCZ could send price up into: Target 1: 107.000 (61.8% retracement of BC) Target 2: 107.600 (78.6% extension and previous structure resistance) Invalidation below 104.780 (break of C low) Risk Management: Entry: 105.100–105.200 on confirmation signal (bullish engulfing / hammer / breakout) Stop Loss: Below 104.780 (below structure + fib invalidation) Targets: 107.000 and 107.600 Risk Profile: Tight invalidation, high reward-to-risk structure Conclusion: CADJPY is offering a clean ABC Bullish structure, completing right at the fib confluence and 200 EMA zone. With a solid base at the PCZ and mapped target levels ahead, this setup aligns well with structured traders looking to enter on confirmation. Stay patient, stay disciplined, and trust your patterns.
Long
by TradeChartPatternsLikeThePros
MONTH START WITH STRONG BUY MOVE ALERT !Currently, price action on the 30-minute chart is showing signs of weakness as it hovers near a key support level at around 3328. The chart has been respecting an ascending trendline, but now we see price attempting to break below this trendline 📉. 🔸 Resistance Zone: 3338 🔸 Support Zone: 3328 🔸 Bearish Target Area: 3315–3300 region 🚨 If the price breaks below the support and the ascending trendline is invalidated, we may see further downside movement, with a potential target near the 3300 zone, which aligns with a previous demand area. 🛑 Watch for confirmation (bearish engulfing candle or retest rejection) before entering a short position. 💡 Bias: Bearish below 3328 📌 Next Key Support: 3290 Let me know your thoughts in the comments! 💬 📊 Trade safe and always manage your risk! 🛡️
TVC:GOLD
by GOLD_INVESTOR_ACADEMY
Never hold a short position blindly!In the 4-hour timeframe, consecutive bullish surges have broken the previous weak consolidation pattern. Focus on the key resistance level around 3350 above; for short-term support below, pay attention to the 3315 level, with the critical support zone between 3295-3300 being the primary focus. Overall, maintain the main theme of participating in long positions at lower levels within this range. For prices in the middle of the range, it is advisable to adopt a "wait-and-see" approach, avoid chasing trades impulsively, and patiently wait for key levels to enter positions.
FXOPEN:XAUUSDLong
by DrewJudson
X1: GOLD/XAUUSD Long Trades Risking 1% to make 1.8%X1: #XAUUSD/#GOLD Long Trades GOLD/XAUUSD Long for day trade, with my back testing of this strategy, it hits multiple possible take profits, manage your position accordingly. Risking 1% to make 1.8% Note: Manage your risk yourself, its risky trade, see how much your can risk yourself on this trade. Use proper risk management Looks like good trade. Lets monitor. Use proper risk management. Disclaimer: only idea, not advice
OANDA:XAUUSDLong
by MuhammadTrades
XAUUSD - SELL After a reasonable big run up like this they will take profits Looks like it's roiling over watching Super Trend and break of Buffer Zone with Bearish Continuation Candle can easily Shoot back up if Wicks but should be plenty of room to make money on this one. Hardest part is being patient Selling seems to capitulate everyone wants to capture as much profit as possible or should I say Algo's NY also current session so they have plenty of push and Greedy as can be ! USD has turned Strong for now also Don't forget to protect profits when you deem fit should it run into profit trading Forex - Gold is very unpredictable their game is to take yr money deliberately - do the opposite just to snag yr hard earned cash. Lets See : )
VANTAGE:XAUUSDShort
by NZ_Shareman
USDCAD – Buy the Dip Near Pivot SupportTrade Idea Type: Buy Limit Entry: 1.3575 Target: 1.3675 Stop Loss: 1.3525 Duration: Intraday Expires: 02/07/2025 06:00 Technical Overview A lower correction is expected, providing an opportunity to buy into a potential reversal setup. Pivot support at 1.3550 aligns with the Buy Limit entry area, offering a solid technical foundation for a rebound. A move above 1.3625 will confirm renewed bullish momentum, supporting a push toward the target at 1.3675. The current risk/reward does not favor chasing at higher levels, making buying dips the preferred strategy. Watch for potential volatility from upcoming U.S. events: Fed Chair Powell speech at 14:30 UTC, and ISM Manufacturing PMI at 15:00 UTC, which may impact USD flows. Key Technical Levels Support: 1.3550 / 1.3525 / 1.3500 Resistance: 1.3625 / 1.3675 / 1.3700 Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
Long
by Signal_Centre1
NZDUSD → Pre-breakout consolidation. One step away from a rallyFX:NZDUSD is consolidating, but the chart shows signs of readiness to shift to a distribution phase, which could lead to a rally. Against the backdrop of a falling dollar, which is continuing its main trend, the NZD may break out of consolidation in a distribution pattern. Since the accumulation is quite large (taking into account the long squeeze), the trend may be strong. A pre-breakout consolidation is forming relative to 0.6080, followed by the price breaking through the resistance of the global trading range. Consolidation above 0.6080 will confirm the breakdown of the structure, which could trigger distribution Resistance levels: 0.6080, 0.612 Support levels: 0.6062, 0.604 The price may be supported by a bullish trend and a decline in the dollar. A breakout from the 4-month consolidation may be accompanied by a continuation of the uptrend until the intermediate high of 0.6355 is reached in the medium term. Best regards, R. Linda!
Long
by RLinda
16
10 Small-Cap Biotechs with Key Catalysts for 2025 July List________________________________________ 🔬 10 Small-Cap Biotechs with Key Catalysts for 2025 July List ________________________________________ 1. Allogene Therapeutics (NASDAQ: ALLO) • Catalyst: Phase 2 data for ALLO-501A (anti-CD19 CAR-T for large B-cell lymphoma) expected in H2 2025; potential pivotal data could lead to regulatory submission. • Highlights: “Off-the-shelf” allogeneic CAR-T approach could transform cell therapy; watch for manufacturing/scalability updates. ________________________________________ 2. Lixte Biotechnology (NASDAQ: LIXT) • Catalyst: Phase 2 combo trial of LB-100 (PP2A inhibitor) + immunotherapy in solid tumors, with key data expected in late 2025. • Highlights: If efficacy signals emerge, could prompt partnerships or additional trials. ________________________________________ 3. Iovance Biotherapeutics (NASDAQ: IOVA) • Catalyst: Commercial launch and sales uptake for AMTAGVI (lifileucel, first FDA-approved TIL therapy in advanced melanoma); upcoming label expansion studies in lung and cervical cancer. • Highlights: Investor focus on launch ramp, real-world data, and new trial initiations in 2025. ________________________________________ 4. RenBio (NASDAQ: RENB) • Catalyst: Phase 1/2 data for RB-100 (bispecific antibody platform in solid tumors) expected mid-to-late 2025. • Highlights: Pipeline progress and partnership announcements possible. ________________________________________ 5. IGM Biosciences (NASDAQ: IGMS) • Catalyst: Phase 2 data for IGM-2323 (CD20 x CD3 bispecific in non-Hodgkin lymphoma) expected early 2025; ongoing updates from IgM antibody platform. • Highlights: Investor interest in clinical safety, efficacy, and potential for big pharma tie-ups. ________________________________________ 6. Zura Bio (NASDAQ: ZURA) • Catalyst: Phase 2b/3 trial start and topline data for tibulizumab (IL-7Ra mAb for autoimmune diseases) expected late 2025. • Highlights: Focus on rare and orphan autoimmune indications. ________________________________________ 7. INmune Bio (NASDAQ: INMB) • Catalyst: Phase 2 Alzheimer’s data (XPro1595, targeting neuroinflammation) and oncology pipeline updates expected H1 2025. • Highlights: Any signal in Alzheimer’s is high-impact; monitoring for FDA guidance. ________________________________________ 8. Veru Inc (NASDAQ: VERU) • Catalyst: Phase 3 trial results for enobosarm (oral SARM) in advanced breast cancer expected 2025; also, COVID/sepsis drug updates. • Highlights: Regulatory clarity and partnership/M&A rumors are potential drivers. ________________________________________ 9. Century Therapeutics (NASDAQ: IPSC) • Catalyst: First-in-human data for iPSC-derived NK and CAR-T cell therapies, with updates expected at major meetings in 2025. • Highlights: Platform validation and early efficacy/safety signals. ________________________________________ 10. ProKidney (NASDAQ: PROK) • Catalyst: Phase 3 pivotal data for REACT (cell therapy for chronic kidney disease/diabetes) due late 2025. • Highlights: If positive, could become the first autologous cell therapy for kidney disease. ________________________________________ 🔎 How to Monitor These Catalysts • FDA submissions/meetings (ALLO, PROK, VERU) • Clinical trial readouts (LIXT, RENB, IGMS, ZURA, INMB, IPSC) • Commercial/launch data (IOVA) • Partnership/M&A activity (IGMS, VERU, RENB) ________________________________________ 📊 Summary Table Ticker Company Upcoming Catalyst/Event Timeframe ALLO Allogene Therapeutics Phase 2 LBCL CAR-T pivotal data H2 2025 LIXT Lixte Biotechnology LB-100 + immunotherapy Phase 2 data Late 2025 IOVA Iovance Biotherapeutics AMTAGVI launch data; label expansions Throughout 2025 RENB RenBio Bispecifics Phase 1/2 data Mid-to-late 2025 IGMS IGM Biosciences IGM-2323 Phase 2 data (lymphoma) Early 2025 ZURA Zura Bio Tibulizumab Phase 2b/3 topline data Late 2025 INMB INmune Bio Alzheimer’s/oncology trial updates H1 2025 VERU Veru Inc Enobosarm Phase 3 (breast cancer) 2025 IPSC Century Therapeutics First-in-human iPSC cell therapy data 2025 PROK ProKidney REACT Phase 3 (CKD) pivotal readout Late 2025 ________________________________________ ⚠️ Word of Caution Small-cap biotech stocks can be extremely volatile, especially around catalyst events (trial data, FDA decisions). Sharp price swings—both up and down—are common. Always conduct your own research and be aware of the risks.
NASDAQ:IBBLong
by ProjectSyndicate
18
NZDCAD Selling Trading IdeaHello Traders In This Chart nzdcad HOURLY Forex Forecast By FOREX PLANET today NZDCAD analysis 👆 🟢This Chart includes_ (NZDCAD market update) 🟢What is The Next Opportunity on NZDCAD Market 🟢how to Enter to the Valid Entry With Assurance Profit This CHART is For Trader's that Want to Improve Their Technical Analysis Skills and Their Trading By Understanding How To Analyze The Market Using Multiple Timeframes and Understanding The Bigger Picture on the Charts
Short
by ForexMasters2000
Bearish drop?XAU/USD is reacting off the resistance which is a pullback resistance that lines up with the 50% Fibonacci retracement and could drop from this level to our take profit. Entry: 3,344.54 Why we like it: There is a pullback resistance that lines up with the 50% Fibonacci retracement. Stop loss: 3,389.14 Why we like it: There is a pullback resistance that lines up with the 71% Fibonacci retracement. Take prpofit: 3,294.89 Why we like it: There is a pullback support level that aligns with the 50% Fibonacci retracement. Enjoying your TradingView experience? Review us! Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
VANTAGE:XAUUSDShort
by VantageMarkets
XAU/USD Start July 20251. i start after XAU/USD break previous High and correction (fibbo 32.0) respected. based on elliot wave strategy we can targeting end of wave 3 at 3353 area and than correction wave 4 (target at fibbo 32.0 - 50.0). after target correction, continue wave 5 at target 3403 area. 2. fundamentally speaking, new months new quarter. there ins't new catalist and sentiment. Macro Economic this week focus on labour market at US and FED projection to cut rate. 3. War at Iran and Israel, Russia and Ukraine, India and Pakistan, Trade War case, etc,. 4. Will be update
FOREXCOM:XAUUSDLong
by RumahCandle
DOW JONES: Final phase of bullish wave has started.Dow is practically overbought on its 1D technical outlook (RSI = 69.306, MACD = 518.450, ADX = 36.217) but that should little affect the heavily bullish price action on the long term. The reason is that after the April bounce on the 1W MA200, Dow entered the final phase of the Bull Cycle that started on the October 2022 bottom and according to all prior bullish waves inside the 16 year Channel Up, it should rise by a minimum of +71%. That gives a TP = 49,000. ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
TVC:DJILong
by InvestingScope
Gold is in the Bearish DirectionHello Traders In This Chart GOLD HOURLY Forex Forecast By FOREX PLANET today Gold analysis 👆 🟢This Chart includes_ (GOLD market update) 🟢What is The Next Opportunity on GOLD Market 🟢how to Enter to the Valid Entry With Assurance Profit This CHART is For Trader's that Want to Improve Their Technical Analysis Skills and Their Trading By Understanding How To Analyze The Market Using Multiple Timeframes and Understanding The Bigger Picture on the Charts
OANDA:XAUUSDShort
by ForexMasters2000
$IREN Long Setup – Ichimoku Cloud Breakout with MACD Momentum IREN is setting up for a strong long opportunity on the daily chart, showing clear bullish structure and momentum. Price has broken above the Ichimoku Cloud with confirmation from both Tenkan-sen and Kijun-sen alignment, and the future cloud remains bullish. This breakout has held for several weeks now, with consistent higher highs and higher lows forming since the April bottom. The MACD is also supporting the move, with both the MACD line and histogram in bullish territory and no immediate signs of bearish divergence. The setup presents a clean risk/reward profile: entry at $10.67, stop at $9.09 just below recent support and Tenkan-sen, and a target at $16.25, which aligns with the R2.5 pivot zone and historical resistance from mid-2023. That’s a risk/reward ratio of 3.53. Volume has been steadily building on up days, suggesting institutional accumulation. If price breaks and holds above the $11.25 pivot (R1), expect continuation toward the next resistance levels at $16.25 and potentially $19+. I’m viewing this as a 2–6 week swing trade based on the daily chart structure and overall trend.
NASDAQ:IRENLong
by aaronkaltman
1
AUDUSD Buyers In Panic! SELL! My dear subscribers, AUDUSD looks like it will make a good move, and here are the details: The market is trading on 0.6571 pivot level. Bias - Bearish My Stop Loss - 0.6603 Technical Indicators: Both Super Trend & Pivot HL indicate a highly probable Bearish continuation. Target - 0.6511 About Used Indicators: The average true range (ATR) plays an important role in 'Supertrend' as the indicator uses ATR to calculate its value. The ATR indicator signals the degree of price volatility. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. ——————————— WISH YOU ALL LUCK
Short
by AnabelSignals
1